T. Rowe Price Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $172M | Buy |
328,110
+14,451
| +5% | +$6.9M | 0.02% | 499 |
|
|
2025
Q4 | $183M | Sell |
313,659
-38,861
| -11% | -$19.8M | 0.02% | 493 |
|
|
2025
Q3 | $162M | Sell |
352,520
-155,944
| -31% | -$58.2M | 0.02% | 510 |
|
|
2025
Q2 | $154M | Sell |
508,464
-34,169
| -6% | -$10.2M | 0.02% | 486 |
|
|
2025
Q1 | $180M | Sell |
542,633
-46,131
| -8% | -$15.2M | 0.02% | 448 |
|
|
2024
Q4 | $182M | Sell |
588,764
-144,933
| -20% | -$40.8M | 0.02% | 450 |
|
|
2024
Q3 | $156M | Sell |
733,697
-125,068
| -15% | -$32M | 0.02% | 485 |
|
|
2024
Q2 | $241M | Buy |
858,765
+55,552
| +7% | +$13.2M | 0.03% | 386 |
|
|
2024
Q1 | $214M | Buy |
803,213
+414,484
| +107% | +$97.7M | 0.03% | 411 |
|
|
2023
Q4 | $89.9M | Buy |
388,729
+218,356
| +128% | +$38.2M | 0.01% | 570 |
|
|
2023
Q3 | $24.9M | Buy |
170,373
+114,970
| +208% | +$21.6M | ﹤0.01% | 869 |
|
|
2023
Q2 | $12.8M | Buy |
55,403
+8,403
| +18% | +$2.28M | ﹤0.01% | 1033 |
|
|
2023
Q1 | $11.4M | Sell |
47,000
-8,250
| -15% | -$2.25M | ﹤0.01% | 1035 |
|
|
2022
Q4 | $16M | Buy |
55,250
+8,629
| +19% | +$844K | ﹤0.01% | 969 |
|
|
2022
Q3 | $3.03M | Buy |
46,621
+4,219
| +10% | +$293K | ﹤0.01% | 1300 |
|
|
2022
Q2 | $3.04M | Sell |
42,402
-2,497
| -6% | -$184K | ﹤0.01% | 1504 |
|
|
2022
Q1 | $4.41M | Sell |
44,899
-3,554
| -7% | -$300K | ﹤0.01% | 1488 |
|
|
2021
Q4 | $4.11M | Sell |
48,453
-9,347
| -16% | -$768K | ﹤0.01% | 1525 |
|
|
2021
Q3 | $4.61M | Sell |
57,800
-18,455
| -24% | -$1.59M | ﹤0.01% | 1520 |
|
|
2021
Q2 | $7.43M | Sell |
76,255
-9,286
| -11% | -$1.1M | ﹤0.01% | 1453 |
|
|
2021
Q1 | $10M | Sell |
85,541
-85,668
| -50% | -$9.99M | ﹤0.01% | 1396 |
|
|
2020
Q4 | $19M | Sell |
171,209
-4,436
| -3% | -$542K | ﹤0.01% | 1236 |
|
|
2020
Q3 | $20.9M | Buy |
175,645
+31,670
| +22% | +$3.44M | ﹤0.01% | 1147 |
|
|
2020
Q2 | $16.3M | Buy |
143,975
+97,257
| +208% | +$9.56M | ﹤0.01% | 1191 |
|
|
2020
Q1 | $3.12M | Sell |
46,718
-701
| -1% | -$58.4K | ﹤0.01% | 1408 |
|
|
2019
Q4 | $4.32M | Sell |
47,419
-95,114
| -67% | -$9.22M | ﹤0.01% | 1422 |
|
|
2019
Q3 | $12.3M | Sell |
142,533
-88,337
| -38% | -$8.29M | ﹤0.01% | 1257 |
|
|
2019
Q2 | $24.2M | Sell |
230,870
-30,667
| -12% | -$3.28M | ﹤0.01% | 1124 |
|
|
2019
Q1 | $32.8M | Buy |
261,537
+518
| +0.2% | +$64.4K | ﹤0.01% | 1021 |
|
|
2018
Q4 | $29.4M | Sell |
261,019
-239,858
| -48% | -$37.1M | 0.01% | 1011 |
|
|
2018
Q3 | $107M | Sell |
500,877
-67,251
| -12% | -$16.9M | 0.02% | 651 |
|
|
2018
Q2 | $159M | Buy |
568,128
+382,109
| +205% | +$67.1M | 0.02% | 531 |
|
|
2018
Q1 | $21.7M | Buy |
+186,019
| New | +$23M | ﹤0.01% | 1156 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
